Critical Review Online Tutoring

Introduction

The selected article is a peer-reviewed paper titled as “The epidemiology of drug use disorders cross-nationally: Findings from the WHO’s World Mental Health Surveys”. This article is written by several authors named as Louisa Degenhardt, Chrianna Bharat, Meyer D. Glantz, Nancy A. Sampson, Kate Scott, Carmen C.W. Lim, Sergio Aguilar-Gaxiola , Ali Al-Hamzawi, Jordi Alonso, Laura H. Andrade, Evelyn J. Bromet, Ronny Bruffaerts, Brendan Bunting, Giovanni de Girolamo, Oye Gureje, Josep Maria Haro, Meredith G. Harris, Yanling He, Peter de Jonge, Elie G. Karam, Georges E. Karam, Andrzej Kiejna, Sing Lee, Jean-Pierre Lepine, Daphna Levinson, Victor Makanjuola, Maria Elena Medina-Mora, Zeina Mneimneh, Fernando Navarro-Mateu, José Posada-Villa, Dan J. Stein, Hisateru Tachimori, Yolanda Torres, Zahari Zarkov, Somnath Chatterji, and Ronald C. Kessler. This article was published in the year 2019 in the “International Journal of Drug Policy”. The article chosen highlights the topic of illicit use of drugs and the prevalence of diseases which has been intensified in recent years, but there exist wide gaps in details regarding the nature of the usage of such drugs , particularly their issue or dependency use that disrupt reliable cross-border contrasts.

Review

This study analyzes data gathered between 2001 and 2015 from 25 WMH countries (n = 27 surveys). Six countries were rated lower or medium-middle-class, six as moderate and fourteen as upper-middle class by the World Bank at the time of gathering of data. Eighteen experiments have been focused on household survey data that are statistically significant; three were metropolitan area representatives; two were chosen areas member and four were Metropolitan area constituents.

The Composite International Diagnostic Interview Version 3.0, a complete organized investigative interview providing authenticated diagnosis of DSM-IV illness, was test for substance use as well as DUDs, as took a lot of other behavioral illnesses by using the WHO WMH Survey. Skilled lay interviewers conducted the interview in person after receiving proper consent in the homes of the respondents.

The interview conducted for this study was normally performed in two sections to minimize participant pressure. Section I contains all core disorders. Secondary Interest Disorders and correspond details and support were also evaluated in Part II. All participants who fulfill inclusion standards for any Part I were undertaken in Part II of the question and answer session, as was the likelihood subset of Part I participants who did not qualify about any illness. The DUDs were evaluated in Part I of the conducted interview in countries like Brazil, Colombia, Mexico, New Zealand and Peru. In Part II of the interview, Argentina, Belgium, Bulgaria, China, Colombia, France , Germany , Italy, Japan, Lebanon, Nigeria, Northern Ireland, Poland, Spain , the Netherlands, the United States and Ukraine were the countries that conducted a complete analysis of DUDs. Moreover, a total of 27 surveys were undertaken where 137,853 participants were carried out in Part I and Part II was performed by 74,926. The present research is concentrated on 90,093 interviewees, who have DUD details.

Summary of key findings

All analyzes were centered on weighted data as well as on stratification and grouping to determine samples were socio-demographically and geographically reflective of target groups. The use of Taylor linearization as applied under Statistical Analysis System (SAS) version 9.4 was calculated to be normal errors. A life table calculation of the age-of-onset circulations of DUDs has been used by SASPROC LIFETEST and is stated as a weighted prevalence. Therefore, the weighted prevalence rates in a cohort segment where participation is contingent on that degree of substance use participation have been reached are published.

The correlation of simple socio-demographic variables with life-time DUD were evaluated with person-year analysis by means of bivariate discrete-time logistic regression assesses. In order to assess past year DUD correlations between lifetime instances, hereinafter described as disorder persistence, similar analytics with standard logistic regression were utilized. Significant tests of F and Wald χ2 were assessed related to the design adjusted factor variance covariance matrices identified at the level of 2-tailed 0.05 statistical importance.

Importance/significance of the study’s results/key findings

The WMH Program provides a structured approach for examining conditions of mental and alcohol use by screening assessments of appropriate adult populations in the population. In regions of varying economic, social and cultural background this study carried out cross-border analyses of the prevalence and associations of drug use disorders (DUDs). There are four tables i.e. lifetime prevalence, past-year prevalence, disorder persistence and socio-demographic correlates of DUDs.

In the table of lifetime prevalence, all of the 27 WMH surveys of all nations together were presented where the World Bank’s income level countries and the WHO areas indicate prevalence of lifetime consumption of drug users, DRAs, DRDs and DUDs. Specific levels of substance use, DRA, DRDs and DUDs vary substantially differ between countries, wealth and areas, and analyzes vary limited to illegal drug addicts for a lifespan.

The table of prevalence for the past year indicates predominance of drug usage, DRA, DRD and DUD and diagnosis for the past year based on the past year. Clear disparities exist between countries, income rates and regions with respect to discretionary drug usage, DRA, DRD and DUD dominance.

Informal indicators for the severity of the condition were measured in the table of disorder persistence, as the amount of DRA, DRD and DUD lifetimes that satisfied the same diagnostic criteria over the last 12 months. Generally, a quarter of those who have ever had DUD in the past year exhibited signs of the condition. The DUC table shows the bivariate relationship between socio-demographic correlates and lifetime DUDs and permanent DUDs.

Limitations, Discussion and Conclusions

Limitation

There are a number of significant limitations to WMH surveys. As the WMH DUDs is evaluated by 27 countries or state areas, not all states, country income levels and other country characteristics have been adequately reflected. The responses in each country differed, the year the tests were performed, and perhaps cross-national gaps in readiness to share personal details concerning substance use as well as issues. The details provided by the respondents is subject to retrospective disclosure limitations, which contribute to possible underestimations of lifetime prevalence. Survival bias can also help to reduce lifetime predictions.

The DUDs evaluation requires few specific limitations. WMH studies are household experiments that have limitations when it is used to test behavior that is less prevalent and less marginalized. The use of illicit drugs can be unusual and locally dispersed and the identification of localized regional ‘pockets of’ drugs by surveys including the WMH survey that depend on stratified sampling procedures can be inappropriate. In addition, the key survey unit usage of households does not reflect vulnerable populations who do not reside in typical household settings like homeless persons, prisons and hospitals, etc. There may also be variations in social, religious and legal circumstances throughout countries that influence the readiness to disclose the use of drugs.

Discussions

While earlier studies have analyzed the general public epidemiology of drug use disorder, the authors know that, by using standardized methodologies and general population surveys, this is the first and most comprehensive cross-border analysis of the prevalence and the comparisons of drug use disorder. There were very different dominance of DUDs i.e. Australia, the USA and New Zealand had the greatest DUDs rates while the African, Latin American, Middle East and Asian countries had a much smaller prevalence. This broad spectrum correlates to other evidence regarding shifts in the prevalence and issue of illegal drug misuse. There were higher DUDs in younger people than elderly adults, which means that the issue of drug use has shifted over time.

In addition, in mid-teen years, the danger of developing DUDs quickly spread to young age people with nearly half of all cases starting from age 20, but the effect continues to be mild. The findings in relation to income were contradictory. The popularity of illegal drug uses and DUD in high-income nations was substantially higher than in low-income nations. It was also clear that the variations found in drug use rates in various countries vary considerably from the trends of disparities in DUD conditions.

In the cross-national analysis of DUDs, there are 2 options. The first concerns the psychiatric importance and accuracy of the signs in all countries, especially for DRA, whose requirements concentrate primarily on the effects of drug use, which are influenced instead of intrinsic to use by social, legal or dynamic web. The second problem is that environmental influences that raise (or reduce) drug level of risk will differ from country to country impacting DUD prevalence. The research findings are essential for policy and planning in the provision and level of services for DUDs.

Conclusions

This article illustrates the considerable difference in the distribution of DUDs throughout different nations, representing many social, ecological, and legal. The research has, however, demonstrated coherence in the beginning and trajectory and a variety of clear correlations through these diverse countries. This study contains basic evidence on associations of DUDs at a country level, but significant diagnostic problems need to be addressed in upcoming cross-national clinical data on drug use disorders and methodological issues.

Reference

Degenhardt, L., Bharat, C., Glantz, M.D., Sampson, N.A., Scott, K., Lim, C.C., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L.H. & Bromet, E. J. (2019). The epidemiology of drug use disorders cross-nationally: Findings from the WHO’s World Mental Health Surveys. International Journal of Drug Policy, 71, 103-112.

[citationic]